The phase 3 trial design evaluating IMNN-001 in newly diagnosed advanced ovarian cancer has been finalized among regulatory ...
Rao, a health-conscious 55-year-old, was diagnosed with a large ovarian mass after experiencing persistent abdominal bloating. Ovarian cancer ... genetic mutations. Awareness and early testing ...
“The Phase 2 OVATION 2 study data are highly encouraging, demonstrating that IMNN-001 is the first immunotherapy to achieve a clinically effective response in ovarian cancer, including benefits ...
BATON ROUGE, La. (WAFB) - In an effort to spread awareness about the disease, the 2025 Geaux Teal Ovarian Cancer Awareness ...